Scribe Therapeutics Inc.
Ownership
Ownership Structure
Who owns Scribe Therapeutics Inc. (SCTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 33.7% of the shares are freely tradable; institutional investors hold 53.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Sanofi | 2.84 | 500,000 | +0.0 | 09/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Genomic Revolution ETF | 7.43 | 1,305,629 | +0.6 | 10/29/2026 |
| T. Rowe Price Health Sciences | 3.89 | 683,719 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.65 | 290,561 | +1,779.3 | 09/30/2026 |
| iShares Russell 2000 ETF | 1.40 | 246,215 | +0.0 | 10/30/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.39 | 244,433 | +0.0 | 09/30/2026 |
| Franklin Biotechnology Discovery A | 0.77 | 135,567 | +0.0 | 09/30/2026 |
| ARK Genomic Revolution ETF A USD Acc | 0.43 | 74,865 | +0.0 | 10/31/2026 |
| Vanguard Russell 2000 ETF | 0.32 | 56,244 | +11,148.8 | 09/30/2026 |
| iShares Russell 2000 Growth ETF | 0.30 | 53,040 | -0.4 | 10/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.